Diversity of pathophysiology in type 2 diabetes shown by islet pathology
Authors:
Open Access
- 25 September 2021
- journal article
- review article
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 13 (1) , 6-13
Abstract
The etiology of type 2 diabetes is multifactorial, in which environmental and genetic factors are involved to varying degrees. This suggests that its pathophysiology might vary depending on the individuals. Knowledge of the differences is critical, because these differences are directly linked to the care and treatment of the patients. Recent studies have attempted to carry out subclassifications of type 2 diabetes based on clinical and genetic differences. However, there is no pathological evidence to support these subclassifications. The pathophysiology of type 2 diabetes is generally divided into insulin resistance in peripheral tissues and pancreatic islet dysfunction. Among them, islet dysfunction causes a deficit in insulin secretion from β‐cells. In particular, a deficit in insulin secretion is ascribed to a combination of disruption of the insulin secretory machinery and a decrease in β‐cell volume in type 2 diabetes. Recent research has suggested that transdifferentiation and dedifferentiation are involved in the decrease in β‐cell volume, and that it might change dynamically depending on the glucose metabolic state. However, it is possible that the numbers of islet cells are decreased in type 2 diabetes. In particular, the loss of endocrine cells due to islet amyloid deposits is an important pathological change in type 2 diabetes in humans. These results show that pathological changes of the islets can be different in each individuals with type 2 diabetes and reflect each pathophysiology, which is useful in establishing further subclassifications and developing tailor‐made therapies for type 2 diabetes.Keywords
This publication has 65 references indexed in Scilit:
- Hyperamylinemia Contributes to Cardiac Dysfunction in Obesity and DiabetesCirculation Research, 2012
- Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humansNature Medicine, 2011
- β-Cell Loss and β-Cell Apoptosis in Human Type 2 Diabetes Are Related to Islet Amyloid DepositionThe American Journal of Pathology, 2011
- Insulin Signaling in α Cells Modulates Glucagon Secretion In VivoCell Metabolism, 2009
- Global and societal implications of the diabetes epidemicNature, 2001
- Identification of a Heparin Binding Domain in the N-terminal Cleavage Site of Pro-islet Amyloid PolypeptideJournal of Biological Chemistry, 2001
- Renal Elimination of Islet Amyloid PolypeptideBiochemical and Biophysical Research Communications, 1997
- Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.Journal of Clinical Investigation, 1994
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitusDiabetologia, 1978